Sun Pharma gains 4% after crashing 14% in past two days

The stock recovered 8% from Friday's low after the Sun Pharma urged the markets regulator to examine the role of some media houses with regard to the allegations raised by the whistle-blower.

Shares of Sun Pharmaceutical Industries gained 4 per cent to Rs 406 apiece on the BSE in intra-day trade on Monday, after the pharmaceutical firm on Friday urged markets regulator Securities and Exchange Board of India (Sebi) to examine the role of some media houses with regard to the allegations raised by the whistle-blower.

The stock recovered 8 per cent from its Friday's intra-day low of Rs 375 on the BSE. In past two trading days, Sun Pharma had plunged 13.7 per cent to a six-year low on Friday, wiping out Rs 15,200 crore from its market valuation amid